Royal Bank Of Canada Biora Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.13 - $12.03 $15 - $1,455	-121 Reduced 87.05%	18 $0
Q3 2022 Nov 14, 2022	SELL	$0.53 - $13.3 $23 - $598	-45 Reduced 24.46%	139 $0
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.22 $516 - $1,126	-923 Reduced 83.38%	184 $0
Q1 2022 May 16, 2022	SELL	$1.11 - $2.25 $933 - $1,892	-841 Reduced 43.17%	1,107 $1,000
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $2,296 - $8,317	1,701 Added 688.66%	1,948 $4,000
Q3 2021 Nov 15, 2021	SELL	$0.67 - $3.41 $547 - $2,785	-817 Reduced 76.79%	247 $0
Q2 2021 Aug 16, 2021	BUY	$2.11 - $4.93 $2,245 - $5,245	1,064 New	1,064 $4,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $41.1M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.